QUICKLINKS AND VIEW OPITONS
FDA approves new weight loss drug Belviq (lorcaserin hydrochloride) on June 27, 2012
Wednesday, June 27, 2012 10:58 am Email this article
The U.S. Food and Drug Administration today, June 27, 2012, approved the weight loss drug Belviq (lorcaserin hydrochloride). Studies of the drug for up to one year showed that increased weight loss by (only) 3 to 3.7 percent more than placebo.
Fda. Fda approves belviq [lorcaserin hydrochloride] to treat some overweight or obese adults. FDA News Press Release. 2012 Jun 27,
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.